Searched over 200M research papers
10 papers analyzed
These studies suggest that the latest treatments for migraine prevention include CGRP-targeting therapies, monoclonal antibodies, and preventive medications like divalproex sodium, topiramate, and onabotulinutoxinA.
19 papers analyzed
Migraine is a common neurological disorder characterized by recurrent headaches that can cause significant disability. Preventive treatments aim to reduce the frequency, severity, and duration of migraine attacks, thereby improving the quality of life for sufferers. Recent research has focused on developing new pharmacological and non-pharmacological therapies to address the limitations of existing treatments.
Calcitonin Gene-Related Peptide (CGRP) Antagonists:
Neurostimulation Techniques:
Established Pharmacological Treatments:
Emerging Pharmacological Agents:
Complementary and Alternative Therapies:
Recent advancements in migraine prevention include the development of CGRP antagonists and various neurostimulation techniques, which show significant promise in reducing migraine frequency and severity. Established pharmacological treatments continue to be effective, while emerging agents and complementary therapies offer additional options for patients. These innovations collectively enhance the therapeutic landscape, providing more tailored and effective preventive strategies for migraine sufferers.
Most relevant research papers on this topic